Nikkei / Financial Times [2015] IECompA m15026 (9 June 2015)

BAILII [Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback]

Irish Competition Authority Decisions


You are here: BAILII >> Databases >> Irish Competition Authority Decisions >> Nikkei / Financial Times [2015] IECompA m15026 (9 June 2015)
URL: http://www.bailii.org/ie/cases/IECompA/2015/m15026.html
Cite as: [2015] IECompA m15026

[New search] [Help]


Nikkei / Financial Times [2015] IECompA m15026 (9 June 2015)

Page Attachment

Transaction details

The proposed acquisition by Baxter Healthcare Limited of certain assets relating to the medical compounding business of Fannin Limited has been cleared by the Competition and Consumer Protection Commission.

Economic sectorMedia merger
Pharmaceutical sector.No

Notification date: Tuesday, June 9, 2015

Parties InvolvedBusiness activities
Baxter Healthcare Limited Baxter Healthcare is a global healthcare company primarily active in the medical device, pharmaceutical and biotechnology sectors.
Fannin LimitedFannin is a provider of medical devices, medicines, diagnostic products and related services in Ireland.
Case Officer AssignedContact Details
Barry O'DonnellTel: 01-470 3696, e-mail: [email protected]

The deadline for any third parties who wish to make submissions regarding the competition aspects of this merger is:

Phase 1Phase 2
Monday, June 22, 2015Monday, September 14, 2015
Date of Requirement for InformationDate Information Received
Friday, July 17, 2015Friday, July 24, 2015
Current status Completed Cleared (Phase 2)

Decision date: Wednesday, October 21, 2015



Competition and Consumer Protection Commission (Ireland) ©


BAILII: Copyright Policy | Disclaimers | Privacy Policy | Feedback | Donate to BAILII
URL: http://www.bailii.org/ie/cases/IECompA/2015/m15026.html